Stockscreener 앱 받기
508.34
1.55%
-8.00
시간 외 거래:
512.00
3.66
+0.72%
Vertex Pharmaceuticals Inc 주식(VRTX)의 최신 뉴스
Vertex Pharmaceuticals Inc Share PriceVRTX, RNS News, Articles, Quotes, & Charts (NASDAQ:VRTX) - Proactive financial news
Vertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript - Fortune
Vertex Pharmaceuticals Highlights Catalyst-Rich Pipeline Beyond Cystic Fibrosis - TradingView
Vertex Pharmaceuticals Maps Growth Beyond CF at Cantor Conference - Yahoo Finance
Vertex Pharmaceuticals Incorporated (VRTX): Crinetics Acquisition Creates a New Growth Engine Beyond Cystic Fibrosis - Yahoo Finance
Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Vertex Pharma stock gains analyst support as JPMorgan raises price target - ad-hoc-news.de
VRTX Reinstated by JP Morgan -- Price Target Raised to $560 - GuruFocus
Vertex trades higher after JPM gives bullish rating - TradingView
Strong Core Business, Raised Guidance Push Vertex Pharmaceuticals Higher - FXEmpire
Executives On The Move: Vertex Expands Its Leadership Team Following Crinetics Acquisition - insights.citeline.com
Vertex Pharma stock heads into the open after a modest gain - ad-hoc-news.de
Vertex Pharma EVP Jasper van Grunsven files initial beneficial ownership statement - Bitget
Q2 Rundown: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs Other Therapeutics Stocks - Yahoo Finance
Vertex Pharmaceuticals (VRTX) executive gets 8,682-share stock grant - Stock Titan
Vertex (NASDAQ: VRTX) executive listed as insider with no reported shares - Stock Titan
Frazier Life Sciences nets $1.1B in long-running biotech fund - Fierce Biotech
Vertex Pharma stock edges near 52-week high as pipeline expansion supports valuation - ad-hoc-news.de
Vertex at Wells Fargo healthcare conference: renal pipeline takes center stage - Investing.com
Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Vertex Pharma stock falls as market digests Crinetics deal and valuation risks - ad-hoc-news.de
Anti-kickback law at play, court tells Vertex as it schools HHS - BioWorld News
Where does Vertex Pharmaceuticals (NASDAQ:VRTX) fit within the Healthcare stocks conversation? - Kalkine Media
Vertex Pharmaceuticals: Solid Growth But Valuation Still Requires Flawless Execution - Seeking Alpha
Vertex Pharma stock heads into the open after a 3.1 percent drop - ad-hoc-news.de
Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.06% on Sep 8: What Signal Does It Send? - TradingKey
Goldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech Stock - The Motley Fool
Vertex Pharmaceuticals (VRTX) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Vertex Pharmaceuticals stock edges lower as market digests strong Q2 figures and insider selling - AD HOC NEWS
Vertex shares fall as investors digest Crinetics acquisition and related financing plans - Quiver Quantitative
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know - Yahoo Finance
Could Nasdaq Focus Lift Attention on Vertex Pharmaceuticals (NASDAQ:VRTX)? - Kalkine Media
Vertex Pharmaceuticals stock steadies near a 52-week high - AD HOC NEWS
David Taylor sold $ VRTX on Aug. 26, 2026 - Quiver Quantitative
Why Vertex stock is sliding today - Wealth Awesome
Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Titan with 4.29% Upside and Robust Buy Ratings - DirectorsTalk Interviews
Vertex Pharma stock slips as revenue and EPS stay in view - AD HOC NEWS
Vertex makes some big people moves, completes its largest acquisition - The Boston Globe
Vertex Fertility Aid Plan Would Violate Kickback Law - Law360
Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now? - The Motley Fool
Here's How Much $100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth Today - Benzinga
Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readout - Fierce Biotech
Is Vertex Pharmaceuticals (VRTX) Undervalued Following Casgevy’s FDA Label Expansion? - simplywall.st
Vertex Tops Citi’s Biotech Picks After Crinetics Deal Completion By Investing.com - Investing.com Canada
Fierce Biotech Layoff Tracker 2026: Novartis nixes Swiss site; TScan telegraphs 75% headcount drop - fiercebiotech.com
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Vertex stock wins Overweight at Morgan Stanley (VRTX:NASDAQ) - Seeking Alpha
How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks? - Barchart.com
Why Is Vertex (VRTX) Up 14.4% Since Last Earnings Report? - Yahoo Finance
Vertex Pharmaceuticals stock hits all-time high at $555.84 By Investing.com - Investing.com Canada
Vertex Pharmaceuticals stock hits all-time high at $555.84 - Investing.com India
Vertex (VRTX) Stock Trades At A Premium On Earnings Yet Looks Fair On Broader Checks - Yahoo Finance
Vertex Pharmaceuticals (VRTX) Appoints Jonathan Poole as New Chi - GuruFocus
Crinetics Director Stephanie Okey Sells All Shares Following Vertex Pharmaceuticals Merger - Kalkine Media
Crinetics Director Wendell Wierenga Reports Stock Disposals Following Vertex Merger - Kalkine Media
Vertex buyout pays Crinetics (CRNX) insider in cash, but his options fared very differently - Stock Titan
Crinetics (NASDAQ: CRNX) director’s stock, options and RSUs all vest and turn to cash in Vertex buyout - Stock Titan
Crinetics (NASDAQ: CRNX) CCO awards vest, then are cashed out or wiped in $85-a-share Vertex merger - Stock Titan
0.58%
자본화:
|
볼륨(24시간):